US 11045461
Compositions of CXCR4 inhibitors and methods of preparation and use
granted A61KA61K31/47A61K31/4709
Quick answer
US patent 11045461 (Compositions of CXCR4 inhibitors and methods of preparation and use) held by X4 Pharmaceuticals, Inc. expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- X4 Pharmaceuticals, Inc.
- Grant date
- Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/47, A61K31/4709, A61K9/485, A61K9/4858